INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.170
-0.050 (-4.10%)
At close: Mar 20, 2026, 4:00 PM EDT
1.130
-0.040 (-3.42%)
Pre-market: Mar 23, 2026, 8:28 AM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $31.1 million as of March 23, 2026. Its market cap has decreased by -82.51% in one year.
Market Cap
31.10M
Enterprise Value
4.45M
1-Year Change
-82.51%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $31.10M, a decrease of -60.03%. That is a compound annual growth rate of -12.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 31.10M | -25.00% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 33.02M |
| Rein Therapeutics | 32.60M |
| Pluri | 31.26M |
| ABVC BioPharma | 31.04M |
| NovaBay Pharmaceuticals | 30.89M |
| Tempest Therapeutics | 30.87M |
| BriaCell Therapeutics | 30.13M |
| Xilio Therapeutics | 29.48M |